Emory Proton Therapy Center Breaks Ground Atlanta

June 24, 2013 — A new first for Georgia was celebrated Thursday, May 2, as Emory Healthcare and the Winship Cancer Institute broke ground on the new Emory Proton Therapy Center. Brasfield & Gorrie, the general contractor on the more than $200 million dollar oncology center, was joined in the celebration by developer Advanced Particle Therapy and elected officials, including Atlanta Mayor Kasim Reed.

In his remarks, Mayor Reed addressed the center’s impact, not only on the lives of patients but also on the city’s economic and research development.

Located in downtown Atlanta at the corner of Peachtree Street and North Avenue, the 107,000 square foot center will accommodate approximately 2,200 cancer patients each year. The facility will open its doors to patients in 2016 after an 18-month commissioning period for the Varian Medical Systems equipment.

The new proton treatment facility will incorporate several unique features, including the 16-foot-thickspecialized shielding walls necessary to house pencil beam scanning equipment. To date, only one proton therapy center in the nation offers pencil beam scanning capabilities and in only one room. The Emory Proton Therapy Center will feature this advanced capability in all five of its treatment rooms.

Under the direction of developer Advanced Particle Therapy, Brasfield & Gorrie is working with Signet Development, Emory Healthcare, VOA Associates and Perkins+Will.

“This facility represents a wonderful opportunity to fulfill a health care need for the people of Georgia and surrounding states. We look forward to a successful building process and turning over a treatment center that will improve the lives of many patients,” said Trey Sanders, regional president of Brasfield & Gorrie.

For more information: www.brasfieldgorrie.com


Related Content

News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now